R&D Systems™ Recombinant Human Podocin/NPHS2 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human Podocin/NPHS2 Protein is derived from E. coli. The Recombinant Human Podocin/NPHS2 Protein has been validated for the following applications: Bioactivity.

Order Info

The product is shipped at ambient temperature.

Specifications

• Accession Number: Q13241
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS
• Gene ID (Entrez): 7827
• Molecular Weight (g/mol): 13 kDa, reducing conditions
• Name: Nephrosis 2, nephrosis 2, idiopathic, steroid-resistant (podocin), NPHS2, PDCN, PDCNSRN1podocin, SRN1
• Quantity: 50μg
• Source: E. coli-derived human Podocin/NPHS2 protein Lys259-Leu383,with an N-terminal Met and a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1μg of protein by LAL method
• Biological Activity: 0.8 to 4μg/mL (ED 50)
• Product Type: Recombinant protein
• Conjugate: Unconjugated
• Species: Cynomolgus Monkey
• Recombinant: Recombinant
• Protein Tag: No
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.

For Research Use Only